Although several studies have reported beneficial actions of activation or reactivation of PPARα signalling on the development and progression of LVH, this remains a controversial issue with other studies reporting limited benefit of PPARα agonists on cardiac hypertrophy or an aggravated hypertrophic response following PPARα activation. This evidence concerns the gene PPARA and cardiac hypertrophy.